New white paper details key technical milestones and validation of the company's proprietary, capsule-based platform to accelerate breakthroughs across human health BOSTON, Jan. 7, 2026 /PRNewswire/ - ...

Founded in October 2023, Somite is building AI foundation models to produce human tissue at scale for cell therapies. These therapies have the potential to cure a wide range of diseases that involve ...

Advanced Micro Devices, Inc. (NASDAQ:AMD) is one of the Top Technology Stocks to Buy According to Hedge Funds. On August 20, Somite.ai announced a strategic investment from AMD Ventures, following the ...

Five scientists walked into a lab late last year and decided to establish a startup combining their wide-ranging expertise, practical experience and breakthrough innovations. The goal of their startup ...

Somite is transforming cell therapy by building large-scale foundation models to rapidly accelerate the development of novel cell therapies, significantly compressing timelines and potentially ...

BOSTON, May 13, 2025 /PRNewswire/ -- Somite AI, a TechBio company leveraging foundation models and proprietary AI to accelerate human cell therapy development, closed its Series A funding round, ...

Somite Therapeutics Inc.’s lead program, SMT-M01, has been awarded orphan drug and rare pediatric disease designations by the FDA for the treatment of Duchenne muscular dystrophy (DMD). The program ...

You may take for granted the fact that your body isn't the same from head to toe. Have you stopped and wondered why? Controlling gene expression to turn on and off at specific times is no simple feat.

BOSTON, Aug. 20, 2025 /PRNewswire/ -- Somite.ai, a company pioneering foundation models for human stem cells, today announced a strategic investment from AMD Ventures, following Somite's $47M Series A ...